Search

Lorraine L Wearley

from Westfield, NJ
Age ~76
Get Report
Also known as:
Lorraine L Wearly, Lorrain Wearley
Phone and address:
620 Raymond St, Westfield, NJ 07090
(908) 654-7663
Related to:
Timothy D Chance, 66Stephen W Wearley, 81Y Saborcolombiano GustoMeredith P Wearley, 44Scott A Wearley, 45
Connected to:
Peggy L Wearley, 60Robin R Wearley, 67Catina M Wearly, 44William L Wearly, 72Whitney Wearmouth, 39Adam H Wearn, 42Robert D Wearn, 94Justin S Wearne, 40Rachel E Wearne, 38Kayla Wearnes, 33

Lorraine Wearley Phones & Addresses

  • 620 Raymond St, Westfield, NJ 07090 (908) 654-7663
  • 620 Raymond St, Westfield, NJ 07090

Business Records

Name / Title
Company / Classification
Phones & Addresses
Lorraine Wearley
Principal
Lorraine Wearley Consulting
Business Consulting Services
620 Raymond St, Westfield, NJ 07090

Publications

Us Patents

Compositions And Methods For Treating Vulvovaginitis And Vaginosis

View page
US Patent:
20030017207, Jan 23, 2003
Filed:
Apr 23, 2002
Appl. No.:
10/128611
Inventors:
Shun Lin - Plainsboro NJ, US
Lorraine Wearley - Westfield NJ, US
Henok Tassew - Highland Park NJ, US
Ying Sun - Belle Mead NJ, US
International Classification:
A61K031/496
A61K009/14
US Classification:
424/486000, 514/254070
Abstract:
This invention relates to compositions and methods for treating vulvovaginitis and vaginosis. The compositions of this invention contain antifungal agents as well as a buffering system that, when administered to a patient's vagina, maintains the pH of the vagina so as to achieve a healthy environment that encourages the growth of appropriate flora. Antifungal agents that are useful in the compositions of this invention include azole antifungal agents. Buffering systems include gluconodeltalactone.

Compositions And Methods For Treating Vulvovaginitis And Vaginosis

View page
US Patent:
20030064103, Apr 3, 2003
Filed:
Mar 28, 2002
Appl. No.:
10/109097
Inventors:
Shun Lin - Plainsboro NJ, US
Lorraine Wearley - Westfield NJ, US
Henok Tassew - Highland Park NJ, US
International Classification:
A61K031/496
A61K009/14
US Classification:
424/486000, 514/254070
Abstract:
This invention relates to compositions and methods for treating vulvovaginitis and vaginosis. The compositions of this invention contain antifungal agents as well as a buffering system that, when administered to a patient's vagina, maintains the pH of the vagina so as to achieve a healthy environment that encourages the growth of appropriate flora. Antifungal agents that are useful in the compositions of this invention include azole antifungal agents. Buffering systems include gluconodeltalactone.

Novel Methods Of Treating Local Fungal And Bacterial Infections

View page
US Patent:
20030130225, Jul 10, 2003
Filed:
Oct 1, 2002
Appl. No.:
10/262389
Inventors:
Nawaz Ahmad - Monmouth Junction NJ, US
Emilia Lonardo - Plainsboro NJ, US
Kalpana Patel - West Windsor NJ, US
Shun Lin - Plainsboro NJ, US
Lorraine Wearley - Westfield NJ, US
J. Matheson - Princeton NJ, US
Brinda Wiita - Princeton NJ, US
International Classification:
A61K031/7076
A61K031/7072
A61K031/496
A61K031/4196
A61K031/4178
A61K031/522
US Classification:
514/045000, 514/049000, 514/263380, 514/254070, 514/397000, 514/383000
Abstract:
This invention relates to novel compositions, methods of use, regimens and kits for treating local fungal and bacterial infections that are susceptible to treatment administered either locally or topically and systemically. The methods of this invention relate to ways in which to relieve symptoms of such infections in an unexpectedly shorter timespan than with conventional treatment with greater predictability than those methods currently known.

Controlled Release Composition

View page
US Patent:
20050074490, Apr 7, 2005
Filed:
Dec 23, 2003
Appl. No.:
10/744751
Inventors:
Shun Lin - Plainsboro NJ, US
Lorraine Wearley - Westfield NJ, US
Dilip Gole - Plainsboro NJ, US
Gary Posage - New Hope PA, US
Paul Wilkinson - Doylestown PA, US
International Classification:
A61K009/22
US Classification:
424468000
Abstract:
The present invention provides a composition comprising a sustained release layer and a fast release layer. The sustained release layer comprises a water-soluble polymer and a first pharmaceutically active agent. The fast release layer comprises a matrix forming agent and a second pharmaceutically active agent. Generally, the composition provides fast and sustained (or controlled) release of a pharmaceutically active agent for at least 6 hours and preferably for at least 1 to 3 days. The composition may be incorporated into a dosage unit form, such as a vaginal insert. Methods of preparing the composition are also provided.

Personal Lubricant Compositions

View page
US Patent:
58855912, Mar 23, 1999
Filed:
May 29, 1997
Appl. No.:
8/865304
Inventors:
Nawaz Ahmad - Monmouth Junction NJ
Gregory E. Koll - Waldwick NJ
Shun Y. Lin - Plainsboro NJ
Rohinton Toddywala - Plainsboro NJ
Lorraine Wearley - Westfield NJ
Assignee:
Johnson & Johnson Consumer Products, Inc. - Skillman NJ
International Classification:
A61K 900
US Classification:
424400
Abstract:
This invention relates to personal lubricant compositions that are at least between three and eighteen times more lubricious than the compositions known previously. The compositions of this invention contain one or more polyhydric alcohols, one or more water-soluble polymers derived from cellulose, water and, optionally, preservatives and alkali metal or alkaline earth metal bases. The compositions of this invention can provide a vehicle for delivering medicaments for contraception and for the treatment and prevention of disease. This invention also relates to methods of using the personal lubricant compositions of this invention.

Stable Hydrated Cephalosporin Dry Powder For Oral Suspension Formulation

View page
US Patent:
55995578, Feb 4, 1997
Filed:
Oct 27, 1994
Appl. No.:
8/325400
Inventors:
Donald A. Johnson - Miami Lakes FL
Lorraine Wearley - Westfield NJ
Rebecca Galeos - Bloomfield NJ
Joel A. Sequeira - New York NY
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 910
A61K 914
A61K 31545
A61K 4700
US Classification:
424500
Abstract:
A dry hydrated cephalosporin, e. g. ceftibuten having about 7 to 14% by weight of water, powder formulation, pharmaceutical compositions in the form of an oral suspension dosage form and a method of making the dry powder formulations are disclosed.
Control profile
Lorraine L Wearley from Westfield, NJ, age ~76 Get Report